{"denomUnitsSelected":"Participants","description":"Minimum residual disease negative rate","reportingStatus":"NOT_POSTED","timeFrame":"Baseline through Month 24","title":"Phase 2: Evaluate Efficacy Endpoints (MRD)","type":"SECONDARY"}